Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
56.3%
% of CANC's 48 holdings also in CNCR
37.5%
% of CNCR's 72 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 4.0% | 2.7% | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 2.4% | 2.4% |
|
BLUEPRINT MEDICINES CORP. | 2.9% | 2.1% | 2.1% |
 |
MERUS N.V. | 3.1% | 1.8% | 1.8% |
|
ARCELLX, INC. | 3.0% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to CNCR
|
ELI LILLY & CO | 5.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.2% |
 |
ASTRAZENECA PLC | 4.3% |
|
NOVARTIS AG | 4.2% |
|
BRIDGEBIO PHARMA, INC. | 4.1% |
|
REVOLUTION MEDICINES, INC. | 3.7% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 3.7% |
 |
DAIICHI SANKYO CO LTD | 3.0% |
|
BEIGENE LTD. SPONSORED ADR | 2.9% |
|
AMGEN INC | 2.9% |
CANC Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.6% |
|
INTREXON CORP | -3.2% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.7% |
|
GENELUX CORP. | -2.5% |
|
COMPASS THERAPEUTICS, INC. | -2.4% |
|
2SEVENTY BIO, INC. | -2.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.0% |
|
HUTCHISON CHINA MEDITECH LIMITED SPO | -1.9% |
|
MONTE ROSA THERAPEUTICS, INC. | -1.8% |
|
IMMUNITYBIO INC | -1.8% |